DNASE1 and systemic lupus erythematosus: On treating patients with SLE with bovine DNase I, clinical responses were observed in six patients and three of them showed a reduction in their levels of anti-DNA antibodies [27] More recently, a phase 1b study of the use of recombinant human DNase I in patients with SLE demonstrated that the treatment was safe.